Czech National Bank Grows Stock Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• The Czech National Bank increased its stake in Intuitive Surgical, Inc. by 6.9%, acquiring an additional 5,692 shares during the second quarter, bringing its total holdings to 87,610 shares worth approximately $47.6 million.
• Intuitive Surgical recently reported earnings of $2.19 per share, surpassing expectations and achieving a 21.4% revenue growth year-over-year.
• The stock has seen various analysts raise their target prices, with a consensus rating of "Moderate Buy" and an average target price of $595.95.

Czech National Bank boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 6.9% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 87,610 shares of the medical equipment provider's stock after acquiring an additional 5,692 shares during the quarter. Czech National Bank's holdings in Intuitive Surgical were worth $47,608,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in ISRG. Chilton Capital Management LLC lifted its position in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 43 shares during the period. Global Financial Private Client LLC lifted its position in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider's stock worth $26,000 after acquiring an additional 38 shares during the period. Elite Financial Inc. acquired a new stake in Intuitive Surgical during the 1st quarter worth approximately $26,000. LFA Lugano Financial Advisors SA acquired a new stake in Intuitive Surgical during the 1st quarter worth approximately $30,000. Finally, TD Capital Management LLC lifted its position in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock worth $30,000 after acquiring an additional 45 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Down 0.2%

Shares of NASDAQ:ISRG traded down $0.84 during trading on Wednesday, hitting $433.66. 1,636,064 shares of the stock were exchanged, compared to its average volume of 2,298,180. The company has a fifty day moving average price of $479.91 and a two-hundred day moving average price of $505.85. The company has a market cap of $155.46 billion, a PE ratio of 60.48, a P/E/G ratio of 4.56 and a beta of 1.61. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company's quarterly revenue was up 21.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.78 EPS. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company's stock, valued at $173,845.44. This represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock worth $21,716,492 in the last ninety days. Insiders own 0.70% of the company's stock.

Analyst Ratings Changes

ISRG has been the subject of a number of recent analyst reports. Evercore ISI raised their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research report on Tuesday, July 8th. Truist Financial lifted their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. Zacks Research lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Erste Group Bank reaffirmed a "hold" rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Citigroup reaffirmed a "buy" rating and issued a $650.00 price objective (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Thirteen analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $595.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.